Ivacaftor
Supporting references
| Link | Tested on | Impact factor | Notes | Publication date |
|---|---|---|---|---|
|
Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells: Nafamostat is the most potent antiviral drug candidate
Preprint |
Calu-3 human airway epithelial cells | comparable IC50 value between Calu-3 and VERO E6 cells |
May/12/2020 | |
|
Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection
3CLpro PapainLpro Enzyme assay Animal model In vitro In silico |
in silico; in vitro enzyme assay; Vero E6 cells; golden Syrian hamsters; SARS-CoV-2 clinical isolate hCoV-19/Taiwan/4/2020 | 9.41 | Inhibited SARS-CoV-2 infection in Vero E6 cells (selectivity index of ca. 3.5). |
Jan/15/2021 |
